Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2013
05/30/2013US20130137733 Di-Substituted Amides for Enhancing Glutamatergic Synaptic Responses
05/30/2013US20130137699 Therapeutic compounds
05/30/2013US20130137691 Derivatives of oxadiazole and pyridazine, their preparation and their application in therapeutics
05/30/2013US20130137690 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
05/30/2013US20130137689 Novel acylpiperazinones and their use as pharmaceuticals
05/30/2013US20130137688 Novel compounds
05/30/2013US20130137687 Novel pyrrolidine derivatives
05/30/2013US20130137686 Benzene, pyridine, and pyridazine derivatives
05/30/2013US20130137684 Haematopoietic-prostaglandin d2 synthase inhibitors
05/30/2013US20130137679 Novel Functionally Selective Ligands of Dopamine D2 Receptors
05/30/2013US20130137678 Antiviral Compounds and Uses Thereof
05/30/2013US20130137675 Heterocyclic compound and use thereof
05/30/2013US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same
05/30/2013CA2856306A1 Selective kinase inhibitors
05/30/2013CA2856301A1 Pyrazine kinase inhibitors
05/30/2013CA2854569A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
05/30/2013CA2854039A1 Isoxazole treatments for diabetes
05/29/2013EP2597089A1 Tricyclic heterocyclic compounds
05/29/2013EP2597088A1 P2x4 receptor antagonist
05/29/2013EP2596793A1 Quinoline derivatives as PI3 kinase inhibitors
05/29/2013EP2595985A1 Isoxazole, isothiazole, furane and thiophene compounds as microbicides
05/29/2013EP2595984A1 Microbicides
05/29/2013EP2595983A1 2,3,5-trisubstituted thiophene compounds and uses thereof
05/29/2013EP2595981A1 Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests
05/29/2013EP2595969A1 Substituted 3-phenyl-1,2,4-oxadiazole compounds
05/29/2013EP2595959A1 Sulfonyl compounds which modulate the cb2 receptor
05/29/2013CN103124729A Pharmaceutically active compounds as Axl inhibitors
05/29/2013CN103124727A Substituted 3-phenyl-1,2,4-oxadiazole compounds
05/29/2013CN103124724A Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
05/29/2013CN103121996A Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
05/29/2013CN102219750B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
05/29/2013CN102146056B N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives
05/29/2013CN102066369B Bromo-phenyl substituted thiazolyl dihydropyrimidines
05/29/2013CN102008459B Antibacterial agents
05/29/2013CN101830894B Benzo[d]oxazole compounds and preparation method thereof
05/29/2013CN101466710B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/28/2013US8450497 Benzimidazole derivatives useful as TRPM8 channel modulators
05/28/2013US8450485 Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative
05/28/2013US8450478 Cyclic guanidine ionic liquid
05/28/2013US8450353 Topical compositions containing desthiobiotin and its derivatives and a method of treating skin
05/28/2013US8450351 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
05/28/2013US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors
05/28/2013US8450316 Niacin mimetics, and methods of use thereof
05/28/2013US8450314 Pyrimidopyridazine derivatives useful as P38 MAPK inhibitors
05/28/2013US8450313 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
05/28/2013US8450310 Isoxazole compounds as inhibitors of heat shock proteins
05/28/2013CA2623958C 2-heteroaryl-substituted indole derivative
05/28/2013CA2577467C Hiv inhibiting 5-heterocyclyl pyrimidines
05/28/2013CA2562160C Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
05/28/2013CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia
05/28/2013CA2485346C Human adam-10 inhibitors
05/28/2013CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/23/2013WO2013074641A1 Piperidinyl- substituted cyclic ureas as gpr119 modulators
05/23/2013WO2013073577A1 Dihydroxy aromatic heterocyclic compound
05/23/2013WO2013072502A1 Pharmaceutically active pyrazine derivatives
05/23/2013WO2013072450A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides iii
05/23/2013WO2013072402A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides ii
05/23/2013WO2013072300A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides
05/23/2013WO2013071694A1 Oxazole compound and preparation method, pharmaceutical composition and use thereof
05/23/2013WO2013071693A1 Oxadiazole compound and preparation method thereof, pharmaceutical composition and use thereof
05/23/2013WO2013049382A3 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
05/23/2013US20130131338 Substituted diketopiperazines as oxytocin antagonists
05/23/2013US20130131321 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
05/23/2013US20130131115 Pest control composition
05/23/2013US20130131096 8-hydroxy-quinoline derivatives
05/23/2013US20130131093 Novel Dihydropyrimidin-2(1H)-One Compounds As Neurokinin-3 Receptor Antagonists
05/23/2013US20130131080 Novel Compounds
05/23/2013US20130131063 Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
05/23/2013US20130131062 Pyridazinones and furan-containing compounds
05/23/2013US20130131061 Novel Estrogen Receptor Ligands
05/23/2013US20130131056 Positive allosteric modulators (pam)
05/23/2013US20130131052 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases
05/23/2013US20130131047 Pharmacokinetically improved compounds
05/23/2013US20130131044 Selective glycosidase inhibitors and uses thereof
05/23/2013US20130131040 Pyrazine kinase inhibitors
05/23/2013US20130131037 2-(heterocyclylbenzyl)pyridazinone derivatives
05/23/2013US20130126856 Compound having indenocarbazole ring structure, and organic electroluminescent device
05/23/2013US20130126429 Amine sulfide scavengers, methods of using, and methods of making
05/23/2013CA2854100A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides iii
05/23/2013CA2853724A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides
05/23/2013CA2853340A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides ii
05/22/2013EP2594566A1 Nitrogenated aromatic heterocyclic ring derivative
05/22/2013EP2594565A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594564A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594563A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594562A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594558A1 Complex compound and optical recording medium containing same
05/22/2013EP2593434A1 Pyridine compounds as sodium channel blockers
05/22/2013EP2593102A1 Oxazole derivatives useful as modulators of faah
05/22/2013CN103119045A Pyrrolopyrimidine compounds and uses thereof
05/22/2013CN103119040A Process for making linezolid
05/22/2013CN103119039A Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
05/22/2013CN103119038A 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists
05/22/2013CN103119028A 1,2,4-Triazolone Derivative
05/22/2013CN103118680A Heteroarylmethyl amides
05/22/2013CN103113364A Preparation method of azilsartan polymorphism
05/22/2013CN103113363A Iloperidone-benzoic acid organic pharmaceutical co-crystal and preparation method thereof
05/22/2013CN103113362A Iloperidone-p-hydroxybenzoic acid organic pharmaceutical co-crystal and preparation method thereof
05/22/2013CN103113361A Iloperidone-saccharin organic pharmaceutical co-crystal and preparation method thereof
05/22/2013CN103113318A New etoxazole compounds, and preparation method and acarid killing activities thereof
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 647